Trial · NCT03192995
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Percentage of Weekly Follow-up Visits of Randomized Study Participants | Mean Percent of Weekly Follow-up Visits by Treatment and Control Arms | Treatment Group | 83 | Standard Deviation 22 | mean percent of visit retention |
| Mean Percentage of Weekly Follow-up Visits of Randomized Study Participants | Mean Percent of Weekly Follow-up Visits by Treatment and Control Arms | Control Group | 81 | Standard Deviation 26 | mean percent of visit retention |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Hyperglycemia | 3 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Hyperglycemia | 1 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Coughing | 2 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Coughing | 1 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Abdominal Pain | 2 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Abdominal Pain | 1 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Rash | 3 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Rash | 0 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Diarrhea | 3 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Diarrhea | 0 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Treatment Group | Other | 2 | Adverse Events | |
| Adverse Clinical Events in the Lorcaserin and Placebo Arms (Descriptive) | Control Group | Other | 4 | Adverse Events | |
| Cumulative Percent Adherence of Medication Events Monitoring (MEMs) Cap | Experimental | 51.6 | Standard Deviation 27.7 | percent adherence | |
| Cumulative Percent Adherence of Medication Events Monitoring (MEMs) Cap | Control | 66.2 | Standard Deviation 21.7 | percent adherence | |
| Proportion of Self-reported Past Week Cocaine Use Among Lorcaserin and Placebo Groups at Baseline and at 12 Weeks | Experimental | Proportion of self-reported weekly cocaine use by Time-Line-Follow-Up (TLFU) at baseline | 12 | Participants | |
| Proportion of Self-reported Past Week Cocaine Use Among Lorcaserin and Placebo Groups at Baseline and at 12 Weeks | Control | Proportion of self-reported weekly cocaine use by Time-Line-Follow-Up (TLFU) at baseline | 6 | Participants | |
| Proportion of Self-reported Past Week Cocaine Use Among Lorcaserin and Placebo Groups at Baseline and at 12 Weeks | Experimental | Proportion of self-reported weekly cocaine use by TLFU at Week 12 | 7 | Participants | |
| Proportion of Self-reported Past Week Cocaine Use Among Lorcaserin and Placebo Groups at Baseline and at 12 Weeks | Control | Proportion of self-reported weekly cocaine use by TLFU at Week 12 | 6 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03192995/results